Olga Guyette | executive |
Christopher Simon | executive |
James D'Arecca | executive |
Anthony Petrone | analyst |
Michael Matson | analyst |
Andrew Cooper | analyst |
Lawrence Solow | analyst |
Joanne Wuensch | analyst |
Michael Petusky | analyst |
Thank you for standing by, and welcome to Haemonetics Corporation's First Quarter Fiscal Year 2025 Earnings Conference Call. [Operator Instructions]. I would now like to hand the call over to Olga Guyette, Vice President, Investor Relations and Treasury. Please go ahead.
Good morning, everyone. Thank you for joining us for Haemonetics' First Quarter Fiscal Year 2025 Conference Call and Webcast.